Article

Red Blood Cell Alloimmunization with a Rare Antigen Causing a Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Report and Review of Management

2020-11-16

Abstract excerpt

A delayed hemolytic transfusion reaction (DHTR) is a potential complication for patients with sickle cell disease (SCD) who develop red blood cell (RBC) alloimmunization to foreign antigens from allogeneic transfusions, resulting in life-threatening hemolytic anemia between 24 hours and 28 days after the transfusion. Guidelines have suggested obtaining an extended RBC antigen profile by genotyping in patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe4764ab-4534-5a75-b11e-d46ade8739f7
DOI: 10.22541/au.160551195.59280116/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Red Blood Cell Alloimmunization with a Rare Antigen Causing a Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Report and Review of ManagementDOI 10.22541/au.160551195.59280116/v1Read

Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.Semantic proximity Read

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.Semantic proximity Read

Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.Semantic proximity Read

Variant RH alleles and Rh immunisation in patients with sickle cell disease.Semantic proximity Read

Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.Semantic proximity Read

Alloimmunization in sickle cell anemia in the era of extended red cell typingSemantic proximity Read

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.Semantic proximity Read

Changing practice: red blood cell typing by molecular methods for patients with sickle cell diseaseSemantic proximity Read

Improving transfusion outcomes in sickle cell disease through extended red blood cell molecular matching.Semantic proximity Read

Development of anti-D in a severe delayed hemolytic transfusion reaction due to DAU3, a partial D variant allele.Semantic proximity Read

Red Blood Cell Alloimmunization in Sickle Cell Disease: Listen to Your AncestorsSemantic proximity Read

Genotyping and the Future of Transfusion in Sickle Cell Disease.Semantic proximity Read